Hormone replacement therapy and screening mammography: Analysis of the results in the Bouches du Rhone programme

Journal of Medical Screening

Volumn 6, Issue 2, 1999, Pages 99-102

  Séradour, Brigitte ^a   Estève, Jacques ^b   Heid, Patrice ^a   Jacquemier, Jocelyne ^c  

^a TIMONE HOSPITAL   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c INSTITUT PAOLI CALMETTES   (France)

Author keywords

Breast cancer; Hormone replacement therapy; Mammography

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; MAMMOGRAPHY; SCREENING TEST;

EID: 0033030986     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.2.99     Document Type: Article

References (26)

1. Nystrom L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8.
2. Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. JAMA 1995;273:149-54.
3. Tabar L, Fagerberg G, Chen HH, et al. Efficacy of breast cancer screening by age. New results from the Swedish two-country trial. Cancer 1995;75:2507-17.
4. Kerlikowske K, Grady D, Barclay J, et al. Effect of age, breast density, and family history on the sensitivity of first screening mammograprry. JAMA 1996;276:33-8.
5. Laya MB, Larson EB, Taplin SH, et al. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996;88:643-9.
6. Cohen EL. Effect of hormone replacement therapy on cancer detection by mammography. Lancet 1997;349:1624.
7. McCann J, Wait S, Séradour B, et al. A comparison of the performance and impact of breast cancer screening programmes in East Anglia, UK and Bouches du Rhône, France. Eur J Cancer 1997;33:429-35.
8. Bonnier P, Bessenay F, Sasco AJ, et al. Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer. Int J Cancer 1998;79: 278-82.
9. Day N, McCann J, Camilleri-Ferrante C, et al for the Quality Assurance Management Group of the East Anglian breast screening programme. Monitoring interval cancers in breast screening programmes: the East Anglian experience J Med Screen 1995;2:180-5.
10. Séradour B, Wait S, Jacquemier J, et al. Dual reading in a non-specialized breast cancer screening programme. The Breast 1996;5:398-403.
11. (a) Breslow NE, Day NE. The analysis of case-control studies. In: Statistical methods in cancer research, Vol 1. Lyon: IARC, 1980:136-46,
12. (b) Breslow NE, Day NE. The design and analysis of cohort studies. In: Statistical methods in cancer research, Vol 2. Lyon: IARC, 1987; 131-50.
13. Laya MB, Gallagher JC, Schreiman JS, et al. Effect of post-menopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-7.
14. Marugg RC, van der Mooren MJ, Hendriks JH, et al. Mammographic changes in postmenopausal women on hormonal replacement therapy. European Radiology 1997;7:749-55.
15. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997;15: 3201-7.
16. Stomper PC, Van Voorhis BJ, Ravnikar VA, et al. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990; 174:487-90.
17. Thurfjell EL, Holmberg LH, Persson IR. Screening mammography: sensitivity and specificity in relation to hormone replacement therapy. Radiology 1997;203:339-41.
18. Litherland JC, Evans AJ, Wilson ARM. The effect of hormone replacement therapy on recall rate in the National Health Service breast screening programme. Clin Radiol 1997;52:276-9.
19. Stomper PC, D'Souza DJ, Dinitto PA, et al. Analysis of parenchymal density on mammograms in 1353 women 25-79 years old. AJR 1996;167:1261-5.
20. Jackson VP, Hendrick RE, Feig SA, et al. Imaging of the radiographically dense breast. Radiology 1993;188:297-301.
21. Blanks RG, Moss SM, Wallis MG. A comparison of two view and one view mammography in the detection of small invasive cancers: results from the National Health Service breast screening programme. J Med Screen 1996;3:200-3.
22. Beral V, Banks E, Reeves G, et al. Hormone replacement therapy and high incidence of breast cancer between mammographic screens. Lancet 1997;349:1103-1.
23. Collaborative group on hormonal factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet 1997;350:1047-59.
24. Harding C, Knox WF, Faragher EB, et al. Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit. BMJ 1996;312:1646-7.
25. Magnusson C, Holmberg L, Norden T, et al. Prognostic characteristics in breast cancer after hormone replacement therapy. Breast Cancer Res Treat 1996;38:325-34.
26. Holli K, Isola J, Cuzick J. Low biologic aggressiveness in breast cancer in women using hormone replacement therapy. J Clin Oncol 1998;16:3115-20.